News - Page 7

Biovac has secured a $108.3 million financing package that will allow the South African pharma company to build the continent’s first end-to-end, multi-vaccine production plant.

Viatris and Teva Pharmaceutical Industries recently launched separate recalls related to dissolution problems for a common anxiety medication and concerns around an unapproved raw material in a high blood pressure patch, respectively.

For Astellas’ chief manufacturing officer, Rao Mantri, Ph.D., production is not just about a reliable supply of a pharmaceutical product. Manufacturing serves as a crucial bridge that helps link promising research to

As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for local drug production with a warning that homes in on the pharmaceutical

Japan’s Shionogi is joining the spate of drugmakers to unveil a U.S. manufacturing commitment, albeit under slightly different circumstances than its peers.

Adragos Pharma, a German CDMO, snapped up one of Europe’s largest sterile injectables production plants for an undisclosed price from Sanofi.

“You want to be holistic, but within a particular specialty,” Ardena CEO Jeremie Trochu recently told Fierce about how the CDMO is navigating rough geopolitical waters.

Amid a major corporate overhaul, Novo Nordisk is pruning the ranks at its Bloomington, Indiana, production facility, which contributes to the blockbuster GLP-1 medications Ozempic and Wegovy.

BASF Pharma Solutions will raise its prices by up to 20% for its excipients and some of its active pharmaceutical ingredients, effective immediately.

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6 after the company submitted additional CMC-related data.